SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZATELLI, Maria Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.572
AS - Asia 14.784
EU - Europa 13.714
SA - Sud America 2.407
AF - Africa 327
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 13
Totale 56.843
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.999
FI - Finlandia 6.237
SG - Singapore 5.842
CN - Cina 3.572
DE - Germania 1.914
BR - Brasile 1.867
VN - Vietnam 1.653
IT - Italia 1.397
HK - Hong Kong 1.245
UA - Ucraina 1.164
GB - Regno Unito 779
TR - Turchia 727
FR - Francia 502
RU - Federazione Russa 489
JP - Giappone 400
SE - Svezia 327
IN - India 316
PL - Polonia 307
MX - Messico 244
CA - Canada 240
AR - Argentina 204
ID - Indonesia 204
BD - Bangladesh 179
NL - Olanda 141
ZA - Sudafrica 126
IQ - Iraq 104
PK - Pakistan 99
ES - Italia 93
EC - Ecuador 82
CO - Colombia 66
AT - Austria 64
BE - Belgio 58
VE - Venezuela 58
UZ - Uzbekistan 53
LT - Lituania 47
PH - Filippine 46
SA - Arabia Saudita 46
MA - Marocco 43
CL - Cile 42
MY - Malesia 38
AE - Emirati Arabi Uniti 32
KE - Kenya 30
PY - Paraguay 27
IE - Irlanda 26
TN - Tunisia 26
JO - Giordania 24
UY - Uruguay 24
EG - Egitto 23
AU - Australia 22
PE - Perù 21
DZ - Algeria 20
IL - Israele 19
AL - Albania 18
NP - Nepal 18
CZ - Repubblica Ceca 16
DO - Repubblica Dominicana 16
JM - Giamaica 16
CH - Svizzera 15
AZ - Azerbaigian 14
KR - Corea 14
LB - Libano 14
CR - Costa Rica 13
DK - Danimarca 13
ET - Etiopia 13
GR - Grecia 13
PS - Palestinian Territory 13
RO - Romania 13
TH - Thailandia 13
BO - Bolivia 12
IR - Iran 12
OM - Oman 12
PA - Panama 12
PT - Portogallo 12
KZ - Kazakistan 11
LV - Lettonia 11
EU - Europa 10
BH - Bahrain 8
NG - Nigeria 8
SY - Repubblica araba siriana 8
BG - Bulgaria 7
GA - Gabon 7
HU - Ungheria 7
KG - Kirghizistan 7
TT - Trinidad e Tobago 7
CY - Cipro 6
GT - Guatemala 6
TW - Taiwan 6
AM - Armenia 5
AO - Angola 5
BY - Bielorussia 5
HR - Croazia 5
KH - Cambogia 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
HN - Honduras 4
LK - Sri Lanka 4
MD - Moldavia 4
MK - Macedonia 4
MT - Malta 4
PR - Porto Rico 4
Totale 56.768
Salva come PNG Salva come JPEG
Città #
Helsinki 5.843
Singapore 3.689
Ashburn 3.513
Woodbridge 2.085
Fairfield 1.883
San Jose 1.763
Chandler 1.487
Jacksonville 1.269
Houston 1.243
Hong Kong 1.230
Santa Clara 1.162
Beijing 1.117
Ann Arbor 842
Seattle 755
Wilmington 708
Cambridge 626
Ho Chi Minh City 536
Los Angeles 438
Izmir 412
Tokyo 389
Dallas 388
Hanoi 382
Nanjing 375
New York 365
Munich 363
Princeton 313
Lauterbourg 308
Warsaw 298
Addison 276
Council Bluffs 271
Ferrara 257
Milan 219
São Paulo 205
Shanghai 190
San Diego 187
Boardman 186
Mexico City 164
Jakarta 141
Orem 125
Turku 122
Shenyang 119
London 117
Nanchang 112
Dearborn 100
Chennai 99
Bremen 94
Chicago 91
Montreal 89
Brooklyn 88
Hefei 88
Tianjin 88
Buffalo 87
Hebei 85
Denver 78
Da Nang 76
Moscow 73
Frankfurt am Main 72
Changsha 70
Toronto 70
Haiphong 69
Johannesburg 68
Atlanta 67
Rome 66
Washington 65
Phoenix 63
Bologna 62
Stockholm 61
Boston 60
The Dalles 60
Manchester 57
Mountain View 56
Jiaxing 55
Falls Church 52
Jinan 52
Rio de Janeiro 51
San Francisco 51
Amsterdam 50
Nuremberg 49
Poplar 49
Brussels 47
Baghdad 45
Guangzhou 45
Tashkent 45
Kunming 44
Falkenstein 43
Belo Horizonte 41
Hải Dương 40
Lappeenranta 39
Redwood City 38
Ankara 36
Norwalk 36
Biên Hòa 34
Mumbai 34
Quito 31
Brasília 29
Campinas 29
Tappahannock 29
Curitiba 28
Dhaka 28
Lahore 28
Totale 39.753
Salva come PNG Salva come JPEG
Nome #
Metodo per modulare la proliferazione del carcinoma midollare della tiroide (MTC) 1.979
Composti farmaceutici che inibiscono la proliferazione di adenomi ipofisari e modi d’uso che ne derivano 1.957
Uso di inibitori delle Cicloossigenasi di tipo 2 come agenti atti a modificare la farmacoresistenza cellulare 1.955
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 430
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 311
Applicability of laparoscopic approach to the resection of large adrenal tumours: a retrospective cohort study on 200 patients 299
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 284
8th edition of the AJCC/TNM staging system of thyroid cancer: What to expect (ITCO#2) 282
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 274
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization 263
Igf-I influences everolimus activity in medullary thyroid carcinoma 262
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression 260
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 252
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 251
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 247
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 247
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 241
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines 239
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies 238
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory 235
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 232
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 232
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 230
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 230
Increase in Peripheral CD3-CD56brightCD16- Natural Killer Cells in Hashimoto's Thyroiditis Associated with HHV-6 Infection 230
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 229
Adrenal cavernous hemangioma: a case report 229
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study 228
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 227
Functional characterization of a new deletion in CDKN1B 5'-UTR region 226
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 223
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 222
The cytotoxic effect of sunitinib on human bronchial carcinoid cell lines and primary cultures is counteracted by EGF and IGF-1 but not by VEGF 218
Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on fine-needle aspiration biopsies 216
Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up. 216
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 216
Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis 215
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 215
Presenza di HHV-6 in campioni tiroidei di pazienti con malattie autoimmuni della tiroide 214
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 214
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 213
Effects of two mTOR inhibitors on in-vitro models of GH-secreting pituitary adenomas 213
X-linked acrogigantism syndrome: clinical profile and therapeutic responses 211
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 211
Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids 211
BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules 210
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 210
Is there a correlation between BRAFV600 mutation, sentinel lymph node biopsy, pathological and clinical parameters in papillary thyroid carcinoma? 208
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 207
Growth hormone induces chemoresistance in breast cancer cells 207
Growth hormone excess promotes breast cancer chemoresistance 205
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 205
Cushing in a Leaf: Endocrine Disruption From a Natural Remedy 204
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 201
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 201
Antiproliferative effects of somatostatin analogs in pituitary adenomas 200
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 200
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 200
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 199
Neck paraganglioma and follicular lymphoma: A case report 199
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 199
Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience 198
MTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors 198
Should aip gene screening be recommended in family members of FIPA patients with R16H variant? 198
EGF and IGF1 affect sunitinib activity in BP-NEN: New putative targets beyond VEGFR? 198
Three-Dimensional Primary Cell Culture: A Novel Preclinical Model for Pancreatic Neuroendocrine Tumors 198
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 197
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 197
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 197
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 197
Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma 196
HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis 196
Therapeutic concentrations of mitotane (o,p′-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model 195
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 194
miR-15a and miR-16-1 down-regulation in pituitary adenomas 193
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease 193
A new VHL polymorphism in a big family from Ferrara 191
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH) 191
Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion 187
VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines 186
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 186
Efficacy of tolvaptan treatment in a patient with syndrome of inappropriate antidiuresis (SIAD) after severe traumatic brain injury 185
Efficacy, safety and adherence to treatment of teriparatide: an observational study 185
A tool to predict survival in stage IV entero-pancreatic NEN 185
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 184
Pituitary side effects of old and new drugs. 184
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 183
mTOR mediated IGF1 proliferative effects on a rat pituitary GH/PRL secreting pituitary adenoma cell line 183
Utilization of luminescent technology to develop a kinase assay: Cdk4 as a model system 181
Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major 181
An unusual association of hyperparathyroidism, ectopic GHRH secrection and bronchial carcinoid in a MEN1 family 180
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 179
Atypical femoral fractures as a complication of long-term bisphosphonate therapy 179
Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma 179
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) 179
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 178
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 178
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells 178
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 177
Glucose metabolism alterations in acromegaly 176
Totale 26.602
Salva come PNG Salva come JPEG
Categoria #
all - tutte 233.508
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 10.581
Totale 244.089
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.081 0 0 0 0 0 0 0 0 0 477 429 175
2021/20222.754 113 256 179 54 118 160 129 151 114 223 266 991
2022/20233.186 321 277 130 435 467 440 168 266 385 26 165 106
2023/20242.076 151 193 103 57 138 315 56 454 58 47 49 455
2024/20257.639 206 165 605 202 929 796 221 311 1.250 974 1.108 872
2025/202626.329 1.974 846 1.797 2.606 3.387 1.455 2.938 1.326 7.721 2.279 0 0
Totale 57.449